Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Blood|July 3, 2010
Sickle cell disease resulting from uniparental disomy in a child who inherited sickle cell traitJeffrey J Swensen, Archana M Agarwal, Jose M Esquilin, et al.
Journal of Oncology|February 18, 2015
Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell CarcinomaSrinivas K Tantravahi, Daniel Albertson, Archana M Agarwal, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 25, 2017
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitorsErin B Bailey, Joseph Merriman, Benjamin Maughan, et al.
British Journal of Haematology|June 14, 2016
Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemiasArchana M Agarwal, Roberto H Nussenzveig, Noel S Reading, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2026
Immunogenicity and safety of co-administration of adjuvanted respiratory syncytial virus prefusion F protein vaccine with 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: a randomized, non-inferiority trialIsabel Leroux-Roels, Muriel Lins, Ronald Surowitz, et al.
The Journal of Medical Investigation : JMI|December 22, 2005
The quest for brain disorder biomarkersChristoph W Turck, Giuseppina Maccarrone, Eser Sayan-Ayata, et al.
Molecular & Cellular Proteomics : MCP|June 16, 2006
Protein biomarkers in a mouse model of extremes in trait anxietyClaudia Ditzen, Archana M Jastorff, Melanie S Kessler, et al.
Plos One|January 26, 2019
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinomaDavid D Stenehjem, Andrew W Hahn, David M Gill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2026
Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of AgeJean-François Roussy, Patrick Dennis, Anil K Gupta, et al.
Pageof 12